Unknown PHASE1 INTERVENTIONAL 2-arm NCT05077462

A Clinical Trial to Evaluate the Safety and Pharmacokinetics of AJU-C52H in Healthy Volunteers

An Open Label, Randomized, Single Dose, 2-sequence, 2-period, Cross-over Phase 1 Study to Evaluate the Safety and Pharmacokinetics of AJU-C52H Compared to Coadministration of C52R1M With C52R2 in Healthy Adult Volunteers

Sponsor: AJU Pharm Co., Ltd.

Conditions Hypertension

Interventions AJU-C52H C52R1M Tab. and C52R2 Tab.

Updated 5 times since 2021 Last updated: Oct 1, 2021 Started: Sep 17, 2021 Primary completion: Apr 30, 2022 Completion: Apr 30, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Hypertension, this trial is ongoing. The trial is conducted by AJU Pharm Co., Ltd. and has accumulated 5 data snapshots since 2021. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE1
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Nov 2023 — Jul 2024 [monthly]

Unknown Status PHASE1

Status: Recruiting → Unknown Status
Nov 2021 — Nov 2023 [monthly]

Recruiting PHASE1

First recorded

Sep 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AJU Pharm Co., Ltd.

Data source: AJU Pharm Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea